[Effect of tranilast ophthalmic solution on allergic conjunctivitis in guinea pigs]
- PMID: 7680329
- DOI: 10.1254/fpj.101.1_27
[Effect of tranilast ophthalmic solution on allergic conjunctivitis in guinea pigs]
Abstract
The effect of the ophthalmic solution of tranilast, an anti-allergic agent, on allergic conjunctivitis was studied in passively sensitized guinea pigs. We determined the content of uranine dye and histamine in tears and histopathologically examined palpebral conjunctiva. After instillation of antigen into the conjunctival sac, inflammation of the palpebral conjunctiva, an increase in leaked dye and the release of histamine were found. In the histopathological study, tranilast (1.0%) suppressed the appearance of edema and infiltration of inflammatory cells. Tranilast suppressed the leakage of uranine in a dose-dependent manner. A 0.5% solution of diphenhydramine also showed the inhibitory effect on the leakage of uranine. The inhibitory effect of 0.5% tranilast on antigen-induced dye leakage and histamine release lasted for 6 hr. These results suggest that topically applied tranilast is effective for allergic conjunctivitis.
Similar articles
-
Inhibitory effect of levocabastine on experimental allergic conjunctivitis in guinea pigs.J Pharmacobiodyn. 1991 Aug;14(8):467-73. doi: 10.1248/bpb1978.14.467. J Pharmacobiodyn. 1991. PMID: 1723098
-
Combination treatment for allergic conjunctivitis - Plant derived histidine decarboxylase inhibitor and H1 antihistaminic drug.Exp Eye Res. 2015 Aug;137:32-8. doi: 10.1016/j.exer.2015.05.020. Epub 2015 May 28. Exp Eye Res. 2015. PMID: 26028180
-
Role of substance P in experimental allergic conjunctivitis in guinea pigs.Methods Find Exp Clin Pharmacol. 1997 Nov;19(9):637-43. Methods Find Exp Clin Pharmacol. 1997. PMID: 9500128
-
Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis.Int Ophthalmol Clin. 2006 Fall;46(4):87-99. doi: 10.1097/01.iio.0000212136.77675.b1. Int Ophthalmol Clin. 2006. PMID: 17060795 Review. No abstract available.
-
Epinastine in the management of ocular allergic disease.Int Ophthalmol Clin. 2006 Fall;46(4):85-6. doi: 10.1097/01.iio.0000212128.45395.a5. Int Ophthalmol Clin. 2006. PMID: 17060794 Review. No abstract available.
Cited by
-
Design of Tranilast-Loaded Cation-Type Contact Lens for Sustainable Ocular Drug Delivery.Pharmaceutics. 2025 May 28;17(6):712. doi: 10.3390/pharmaceutics17060712. Pharmaceutics. 2025. PMID: 40574025 Free PMC article.
-
Development of Sustained-Release Ophthalmic Formulation Based on Tranilast Solid Nanoparticles.Materials (Basel). 2020 Apr 3;13(7):1675. doi: 10.3390/ma13071675. Materials (Basel). 2020. PMID: 32260210 Free PMC article.
-
An in situ Gelling System Based on Methylcellulose and Tranilast Solid Nanoparticles Enhances Ocular Residence Time and Drug Absorption Into the Cornea and Conjunctiva.Front Bioeng Biotechnol. 2020 Jul 7;8:764. doi: 10.3389/fbioe.2020.00764. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32733870 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources